Orbital Therapeutics

About:

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Top Investors: Andreessen Horowitz, ARCH Venture Partners, Invus, Alexandria Venture Investments, Redmile Group

Description:

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. To produce an extended portfolio of medications, the company is developing an innovative platform at the confluence of RNA technology, delivery techniques, data analytics, and automation.

Total Funding Amount:

$270M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)orbitaltx.com

Founders:

Carol Suh, Drew Weissman, Ph.D, Gene Yeo, Giuseppe Ciaramella, Howard Chang, John Maraganore, Kristina Burow, Ravi Majeti

Number of Employees:

11-50

Last Funding Date:

2023-04-26

IPO Status:

Private

Industries: